These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 13882815)

  • 1. Use of poliomyelitis virus vaccine in light mineral oil adjuvant in a community immunization program and report of reactions encountered.
    CUTLER JC; LESESNE L; VAUGHN I
    J Allergy; 1962; 33():193-209. PubMed ID: 13882815
    [No Abstract]   [Full Text] [Related]  

  • 2. Applied immunology of mineral oil adjuvants.
    DAVENPORT FM
    J Allergy; 1961; 32():177-89. PubMed ID: 13719954
    [No Abstract]   [Full Text] [Related]  

  • 3. [Serological response of guinea pigs to inoculation with anti-poliomyelitis vaccine containing adjuvant substances].
    PICCIOTTO L; BRANCATO P
    Riv Ist Sieroter Ital; 1960; 35():70-6. PubMed ID: 14432717
    [No Abstract]   [Full Text] [Related]  

  • 4. REACTIONS TO OIL-ADJUVANT TRACHOMA VACCINE: TAIWAN 1962-1964.
    NEAVE C; WOOLRIDGE RL
    Tsa Chih Gaoxiong Yi Xue Yuan Tong Xue Hui; 1965 Jan; 64():1-6. PubMed ID: 14281349
    [No Abstract]   [Full Text] [Related]  

  • 5. POLIOVIRUS VACCINES IN MINERAL OIL ADJUVANT. II. CLINICAL REACTION AND ANTIBODY RESPONSE.
    STONE S; HU R; KRUGMAN S; TYTELL AA; HILLEMAN MR
    J Allergy; 1963; 34():420-5. PubMed ID: 14066384
    [No Abstract]   [Full Text] [Related]  

  • 6. A community vaccination program. A report on the introduction and subsequent use of Salk polio vaccine in Omaha and Douglas County.
    LYMAN ED; ADAMS B
    Nebr State Med J; 1962 May; 47():290-6. PubMed ID: 14467569
    [No Abstract]   [Full Text] [Related]  

  • 7. POLIOVIRUS VACCINES IN MINERAL OIL ADJUVANT. I. ANIMAL TOXICITY AND SEROLOGIC RESPONSE DATA.
    HILLEMAN MR; HAMPIL B; SWEET BH
    J Allergy; 1963; 34():413-9. PubMed ID: 14066383
    [No Abstract]   [Full Text] [Related]  

  • 8. Control of influenza and poliomyelitis with killed virus vaccines.
    Salk J; Salk D
    Science; 1977 Mar; 195(4281):834-47. PubMed ID: 320661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of plasma-cell neoplasms in strain BALB/c mice with mineral oil and mineral oil adjuvants.
    POTTER M; BOYCE CR
    Nature; 1962 Mar; 193():1086-7. PubMed ID: 14488296
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of adjuvants to facilitate studies on the immunologic classification of poliomyelitis viruses.
    SALK JE; LEWIS LJ; YOUNGNER JS; BENNETT BL
    Am J Hyg; 1951 Sep; 54(2):157-73. PubMed ID: 14877797
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies of arthritis and other lesions induced in rats by injection of mycobacterial adjuvant. III. Lesions of the eye.
    WAKSMAN BH; BULLINGTON SJ
    Arch Ophthalmol; 1960 Nov; 64():751-62. PubMed ID: 13782607
    [No Abstract]   [Full Text] [Related]  

  • 12. Amyloidosis in mice following injections with Freud's adjuvant, its components separately and homologous liver-adjuvant mixture.
    TAL C; LAUFER A
    Br J Exp Pathol; 1960 Dec; 41(6):605-9. PubMed ID: 13775000
    [No Abstract]   [Full Text] [Related]  

  • 13. Trivalent poliomyelitis vaccine administered orally in a cloistered community.
    RUEGSEGGER JM; DELERY M
    N Engl J Med; 1960 Sep; 263():596-8. PubMed ID: 14440041
    [No Abstract]   [Full Text] [Related]  

  • 14. SEROLOGICAL STUDIES ON ADULT VOLUNTEERS INOCULATED WITH OIL-ADJUVANT ASIAN INFLUENZA VACCINE. REPORT TO THE M.R.C. COMMITTEE ON INFLUENZA AND OTHER RESPIRATORY VIRUS VACCINES.
    HOBSON D; LANE CA; BEARE AS; CHIVERS CP
    Br Med J; 1964 Aug; 2(5404):271-4. PubMed ID: 14160207
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of oil adjuvants in therapeutic vaccines.
    Aucouturier J; Ascarateil S; Dupuis L
    Vaccine; 2006 Apr; 24 Suppl 2():S2-44-5. PubMed ID: 16823921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic classification of poliomyelitis viruses. IV. Results of typing by neutralization of prototype viruses with antiserum produced by vaccinating monkeys with unknown strain and an adjuvant.
    SALK JE; YOUNGNER JS; LEWIS LJ; BENNETT BL
    Am J Hyg; 1951 Sep; 54(2):255-67. PubMed ID: 14877806
    [No Abstract]   [Full Text] [Related]  

  • 17. CLINICAL TRIALS OF OIL-ADJUVANT INFLUENZA VACCINES, 1960-3. REPORT TO THE MEDICAL RESEARCH COUNCIL BY ITS COMMITTEE ON INFLUENZA AND OTHER RESPIRATORY VIRUS VACCINES.
    UJHAZY V
    Br Med J; 1964 Aug; 2(5404):267-71. PubMed ID: 14160206
    [No Abstract]   [Full Text] [Related]  

  • 18. Production of formalinized poliomyelitis vaccine (Salk-type) on a semi-industrial scale.
    GOLDBLUM N; GOTLIEB T; MILLER G
    Bull World Health Organ; 1957; 17(6):1001-23. PubMed ID: 13511145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [EXPERIMENTAL STUDIES ON LIVER DAMAGE INDUCED BY ADJUVANT].
    TAKEDA K
    Arerugi; 1965 Feb; 14():54-9. PubMed ID: 14329546
    [No Abstract]   [Full Text] [Related]  

  • 20. Small-scale trial with Sabin attenuated type 1 poliovirus vaccine in a semi-closed community.
    HOSKINS JM; HOBSON D; UDALL V; MADLAND T; GOFFE AP; STUART-HARRIS CH; HERZOG EG
    Br Med J; 1962 Mar; 1(5280):747-53. PubMed ID: 14449180
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.